1425 companies · 1446 sector slots · 20 sectors · 23 below Rs1000cr and not scanned · long-term lens
Trend Spotlight
Solar Industries' defence order book keeps expanding, undercutting the 'plateau' bear case built into its valuation.
Solar Industries entered FY27 with a ~Rs 21,350cr total order book (~Rs 18,000cr+ defence), and has since stacked fresh defence export wins of Rs 399cr, Rs 1,076cr, Rs 830cr and Rs 1,400cr through 2026 -- materially beyond the plateau level the open ledger claim was built on, meeting that claim's expansion falsifier. The free-cash-flow and coverage-ratio compression (13x to 5.7x) the same claim also cited remains unaddressed by any source found this session, so the growth story looks intact while the valuation-support half of the bear case is still untested.
RBI's rate call lands today against a disputed CPI print, a second straight Fed cut, and no reliable GIFT Nifty read.
The RBI MPC's bi-monthly decision is due, with pre-meeting consensus favouring a hold at 5.25% though some brokerages flag a hawkish tilt that could matter for December; India's September CPI print is disputed between sources (one shows a 99-month-low 1.54%, another 5.02%) and should be treated as unresolved pending MOSPI's own release. The US Fed delivered a second straight 25bp cut amid a government shutdown clouding its own data, and Brent is trading near $91.93/bbl. Sensex and Nifty closed firmly higher in the prior session, extending a three-day winning streak led by IT and financials. No usable overnight GIFT Nifty or Asia/US cue could be sourced for today's open -- that gap should be read as no signal found, not as neutral.
Good business, bad price today (Value 1/5) — PEG 7.83; P/E cheaper than 24% of sector peers (P/E 50.89); EV/EBITDA 25.8, B/M 0.172. Watch for a better entry.
Good business, bad price today (Value 2/5) — PEG 2.73; P/E cheaper than 37% of sector peers (P/E 37.71); EV/EBITDA 19.6, B/M 0.188. Watch for a better entry.
Good business, bad price today (Value 1/5) — PEG 1.19; P/E cheaper than 30% of sector peers (P/E 38.37); EV/EBITDA 108.7, B/M 0.276. Watch for a better entry.
Source: NSE event calendar, filtered to the 1425 tracked names.
Market Overview
Index
Close
Points
Change
P/E
P/B
Nifty 50
22,776.10
▲ +220.35
▲ +0.98%
19.49
2.80
Nifty Next 50
69,973.70
▲ +759.95
▲ +1.10%
18.34
3.36
Nifty 500
22,202.85
▲ +231.25
▲ +1.05%
21.90
3.11
Nifty Bank
55,128.40
▲ +414.30
▲ +0.76%
13.07
1.66
NIFTY Midcap 100
59,761.20
▲ +637.55
▲ +1.08%
28.19
3.80
▲ 1903 advancing■ 33 unchanged▼ 734 decliningof 2670 equities, vs the 2026-10-05 close
Cash market, ₹ crore
FII / FPI net
▼ -2,961.30
bought 11,259 · sold 14,220
DII net
▲ +5,088.92
bought 20,146 · sold 15,057
FII / FPI
DII
Source: NSE ind_close_all_20261006
(levels, index P/E and P/B) and the full-market bhavcopy (breadth).
Index P/E from NSE's official daily index file.
Since We Flagged
The desk's track record — every call it has published, scored over the
stretch it actually stood: from the close on the day it was made (restated for any
split or bonus) to the day the desk changed it, the name left coverage, or today.
Each is set against Nifty 500 over the same window. A BUY should beat it; an AVOID
should lag it.
3538 calls scored since Wed, 5 Aug 2026: 1382 standing, 1566 closed when the desk changed the call, 590 closed when the name left coverage (at its last published close). 2012 of them are the call a name was given on entering coverage, not one the desk changed to. 1370 more standing calls with history are not shown — this table is the 12 that have moved most against Nifty 500 since they were made. 38 calls published this session are not scored yet — no session to move in. 22 have no cached close at one end of their window and are not scored. 8 entry prices restated for a split or bonus inside the window (marked adj.).
Cohance Lifesciences hit with a second USFDA Form 483 in weeks, clouding its pending AVOID->HOLD flip Pharmaceuticals
Cohance's Jaggaiahpet API facility drew a Form 483 with five observations (Sept 14-19 inspection), following four observations at its Shamshabad plant weeks earlier (Aug 27-Sept 4). Two facilities flagged within weeks of each other is a real negative for the pending AVOID->HOLD call upgrade, though confined to this one company rather than a sector-wide pharma issue.
Shivalik Bimetal's CFO resigns as the company secures consent for a new Pune EV-component facility Metals & Mining
CFO Rajeev Ranjan resigned for personal reasons effective Oct 31, 2026 -- a modest governance flag against the pending SBCL HOLD->QUALITY-WAIT call flip -- while the company separately won Maharashtra Pollution Control Board consent for Phase I of a new Pune facility (valid to June 2032) expanding EV/energy-storage component capacity. Net read is mixed, not a clean catalyst either way.
Chalet Hotels outlines a 5,500-key-by-FY30 expansion plan and a new luxury brand launch Hospitality & Tourism
Following its Sept 21 AGM, Chalet Hotels is in active investor outreach detailing a premium leisure-led growth phase: 5,500 keys by FY30, talks on luxury acquisitions, and a new in-house lifestyle brand, ATHIVA, starting with The Dukes Retreat, Khandala. This is consistent with the pending CHALET QUALITY-WAIT->BUY flip but largely reiterates FY26 results already reported in late August rather than confirming new information.
DCB Bank's asset quality keeps improving into FY27, with RBI seating a new chairman Banks
DCB Bank's Q1 FY27 delivered record profit with GNPA at 2.43% and NNPA at 0.84% (improved from 2.99%/1.12% a year earlier) and a 17.03% capital adequacy ratio. RBI approved Pushan Mahapatra as Non-Executive Part-Time Chairman for a 3-year term. No client loss or governance red flag found, supporting the existing BUY.
Kirloskar Pneumatic: a reported profit dip collides with a bullish order-book growth call ahead of its pending downgrade Capital Goods
One source reports Kirloskar Pneumatic's net profit fell 38% in a recent quarter, while separate sell-side coverage points to a healthy ~Rs 1,853cr order book (2.6x FY26 Q4 revenue) and expects 20% YoY revenue/PAT growth in FY27 on new compressor launches. The two pictures disagree on direction just as the pending BUY->QUALITY-WAIT flip awaits confirmation.
Entry score is 40% cheap-vs-history + 25% quality trend + 20% news catalyst + 15% technicals, for the 5 sectors with a researched catalyst. The other 15 show —: no catalyst was researched for them, so their score renormalises over the remaining three inputs rather than assuming a neutral headline. ≥62 accumulate · 45–61 watch · <45 avoid.
Source: data/verdicts.json × NSE sector index closes.
Stocks to Watch
Split evenly across large/mid/small/micro cap so this list isn't one
tier's picks — new calls first, then the highest long-term composites within each.
Micro-cap names are boxed and flagged Highly Volatile — worth
watching, not a call to buy — since their price swings run about twice every other
tier's. Each card shows the figures that selected it — open the desk for the full
six-lens panel.